'First-in-human' trials overhauled

被引：0
|
作者：
不详
机构：
来源：
SCIENCE | 2016年 / 353卷 / 6298期
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
下载
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [21] Who Should Participate in First-In-Human Pig Xenotransplant Clinical Trials?
    Gusmano, M. K.
    Maschke, K.
    Gacki-Smith, J.
    Matthews, M.
    Traboulsi, K.
    Manning, D.
    Uriarte, J.
    Leventhal, J.
    Gordon, E. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S937 - S937
  • [22] Clinical Development Strategies and Outcomes in First-in-Human Trials of Monoclonal Antibodies
    Tosi, Diego
    Laghzali, Yassine
    Vinches, Marie
    Alexandre, Marie
    Homicsko, Krisztian
    Fasolo, Angelica
    Del Conte, Gianluca
    Durigova, Anna
    Hayaoui, Nadia
    Gourgou, Sophie
    Gianni, Luca
    Mollevi, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : 2158 - U191
  • [23] The inherent ethical challenge of first-in-human pluripotent stem cell trials
    Habets, Michelle G. J. L.
    van Delden, Johannes J. M.
    Bredenoord, Annelien L.
    REGENERATIVE MEDICINE, 2014, 9 (01) : 1 - 3
  • [24] Clinical pharmacology considerations for first-in-human clinical trials for enzyme replacement therapy
    Stern, Sydney
    Wang, Jie
    Li, Ruo-Jing
    Hon, Yuen Yi
    Weis, Shawna L.
    Wang, Yow-Ming C.
    Schuck, Robert
    Pacanowski, Michael
    JOURNAL OF INHERITED METABOLIC DISEASE, 2024,
  • [25] OPTIMIZING FIRST-IN-HUMAN (FIH) TRIALS USING AGILE DESIGNS: A SIMULATION EVALUATION
    Perlstein, Itay
    Bolognese, Jim
    Krishna, Rajesh
    Wagner, John A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1097 - 1097
  • [26] An Industry Perspective on the 2017 EMA Guideline on First-in-Human and Early Clinical Trials
    DeGeorge, Joseph
    Robertson, Sarah
    Butler, Lynne
    Derzi, Mazin
    Stoch, S. Aubrey
    Diaz, Dolores
    Hartke, James
    Guzzie-Peck, Peggy
    Mortimer-Cassen, Elisabeth
    Bogdanffy, Matthew
    Will, Yvonne
    Greene, Nigel
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 566 - 569
  • [27] How Often Do Safety Signals Occur by Chance in First-in-Human Trials?
    Clayton, Gemma L.
    Schachter, Asher D.
    Magnusson, Baldur
    Li, Yue
    Colin, Laurence
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (05): : 471 - 476
  • [28] Improving consent forms for first-in-human trials through participant feedback.
    Sibold, Hannah Claire
    Campbell, Gavin Paul
    Bourgeois, John
    Dixon, Margie D.
    Harvey, R. Donald
    Pentz, Rebecca D.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] First-In-Human Stem Cell Trials in Huntington Disease: A Bioethics Survey.
    Duffy, A.
    Martin, A.
    Yarborough, M.
    O'Keefe, M.
    Michie, M.
    Swadell, D.
    Wheelock, V.
    NEUROTHERAPEUTICS, 2016, 13 (01) : 244 - 245
  • [30] Evaluation of Agile Designs in First-in-Human (FIH) Trials-A Simulation Study
    Perlstein, Itay
    Bolognese, James A.
    Krishna, Rajesh
    Wagner, John A.
    AAPS JOURNAL, 2009, 11 (04): : 653 - 663
12345